Montelukast is used as a long-term (maintenance) treatment to prevent or treat asthma. It may also be used in people older than 14 years to prevent asthma brought on by exercise (bronchospasm).
This medication is also used to treat allergic rhinitis, also known as allergies or hay fever.
Montelukast works by blocking certain substances (leukotrienes) in the body. This effect helps to decrease symptoms (e.g., breathing...
Read moreMy e-mail is buzzing. "Have you seen the news about Singulair? Are you worried?" The short answer is, "No, I'm not concerned at all." ... Read more »
Did you see the reports last week that Singulair was going to be investigated by the Food and Drug Administration for reports of a "casual... Read more »
What is the concern about Singulair (montelukast)?Singulair is a major drug in asthma treatment – it is important to review recent developments and... Read more »
The Food and Drug Administration has approved Singulair to prevent exercise-induced asthma (EIA) in patients ages 15 years and older. EIA is a... Read more »
This is a study to evaluate the treatment of patients entering emergency rooms with asthma attacks when they are given an intravenous form of MK0476... Read more »
This is a study to compare the effects of Flovent (fluticasone propionate), Advair (fluticasone propionate/salmeterol), and Singulair (montelukast)... Read more »
The U.S. Food and Drug Administration (FDA) has requested that asthma drugs in the leukotriene receptor agonists category be given a "precaution" on... Read more »